CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

NCT06834282 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

AML
Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia

Interventions

DRUG: CER-1236
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Mesna

Sponsor

CERo Therapeutics Holdings, Inc.